Special Report: LTR Pharma has co-founded and secured a 33% equity ownership in LevOmega, an Australian company focused on ...

Pfizer (PFE), a pharmaceutical and biotechnology company, rose to great heights during the pandemic with its COVID-19 vaccine ...

An update from Eupraxia Pharmaceuticals ( ($TSE:EPRX) ) is now available. On September 22, 2025, Eupraxia Pharmaceuticals announced a proposed ...

Innovative AI-powered monitoring enables a leading pharmaceutical and biotechnology company to optimize transport modes without compromising product integrity ...

Though supported by Big Pharmas like Sanofi and Novo Nordisk parent company Novo Holdings, MapLight has readily burned through heaps of cash. The biotech’s current deficit is $251.6 million as of June ...

A new training space for future biopharmaceutical employees is now operational at the Pitt County Technology Enterprise ...

Eupraxia Pharmaceuticals Inc. ('Eupraxia” or the 'Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is one of the best affordable biotech stocks to invest in now . Rigel ...

Recursion Pharmaceuticals (RXRX) ended the recent trading session at $4.98, demonstrating a +1.32% change from the preceding day's closing price. The stock's change was more than the S&P 500's daily ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), a clinical-stage biotech, is pioneering the use of artificial intelligence and ...

Verrica CEO Jayson Rieger said a $10 million payment from its licensing partner will immediately strengthen the firm's ...